A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

If the Rams are looking to free up cap space, these 6 players could be on the chopping block – including Cooper Kupp ...

Earleen Fisher, an editor and writer whose career across five decades with The Associated Press gave her a front-row seat to some of the late 20th century’s most chaotic and challenging news stories, ...

Steuart Smith's Parkinsonism diagnosis has led the Eagles guitarist to retire after 24 years. The guitarist had been ...

Bajaj Healthcare has received approval from India's Drug Controller General to manufacture Pimavanserin, a drug for Parkinson's-related hallucinations and delusions. Pimavanserin, already popular in ...